Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.494
Bid: 1.472
Ask: 1.506
Change: -0.006 (-0.40%)
Spread: 0.034 (2.31%)
Open: 1.53
High: 1.53
Low: 1.462
Prev. Close: 1.50
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB FY20 Consolidated Results

1 Mar 2021 07:00

RNS Number : 6095Q
Commercial Intnl Bank (Egypt) SAE
01 March 2021
 

 

.Click on, or paste the following link into your web browser, to view the associated PDF document

http://www.rns-pdf.londonstockexchange.com/rns/6095Q_1-2021-3-1.pdf 

Commercial International Bank (Egypt) S.A.E.

Consolidated Financial Statements

December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Consolidated Balance Sheet as of December 31, 2020

 

 

Notes

Dec. 31, 2020

 

Dec. 31, 2019

 

 

EGP Thousands

 

EGP Thousands

 

Assets

 

 

 

 

 

Cash and balances at the Central Bank

15

33,768,549

 

28,273,962

 

Due from banks

16

87,426,301

 

28,353,366

 

Loans and advances to banks, net

18

776,980

 

625,264

 

Loans and advances to customers, net

19

119,570,005

 

119,321,103

 

Derivative financial instruments

20

248,759

 

216,383

 

Investments

 

 

 

 

 

- Financial Assets at Fair value through P&L

21

359,959

 

418,781

 

- Financial Assets at Fair value through OCI

21

148,118,372

 

89,897,257

 

- Amortized cost

21

25,285,225

 

107,225,613

 

- Investments in associates

22

139,871

 

107,693

 

Other assets

23

9,175,525

 

9,748,143

 

Goodwill

42

178,782

 

-

 

Intangible Assets

43

44,920

 

-

 

Deferred tax assets (Liabilities)

31

437,772

 

350,339

 

Property, plant and equipment

24

2,311,147

 

2,204,464

 

Total assets

 

427,842,167

 

386,742,368

 

Liabilities and equity

 

 

 

 

 

Liabilities

 

 

 

 

 

Due to banks

25

8,817,535

 

11,810,607

 

Due to customers

26

341,169,450

 

304,448,455

 

Derivative financial instruments

20

331,073

 

282,588

 

Current tax liabilities

 

859,582

 

4,639,364

 

Other liabilities

28

5,735,269

 

8,396,794

 

Other loans

27

7,746,946

 

3,272,746

 

Provisions

29

3,223,501

 

2,011,369

 

Total liabilities

 

367,883,356

 

334,861,923

 

Equity

 

 

 

 

 

Issued and paid-up capital

30

14,776,813

 

14,690,821

 

Reserves

33

33,094,580

 

24,344,815

 

Reserve for employee stock ownership plan (ESOP)

33

1,064,648

 

963,152

 

Retained earnings *

33

10,539,715

 

11,881,657

 

Total equity

 

59,475,756

 

51,880,445

 

Minority interest

 

483,055

 

-

 

Total minority interest, equity and net profit for the period/year

59,958,811

 

51,880,445

 

Total liabilities and equity

 

427,842,167

 

386,742,368

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

(Audit report attached)

 

 

 

 

*

Including net profit for the current year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

Sherif Samy

 

CEO & Board member

 

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated income statement for the year ended December 31, 2020

 

 

 

 

 

 

 

 

 

 

Notes

 

 

Dec. 31, 2020

 

 

 

Dec. 31, 2019

 

 

 

 

EGP Thousands

 

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

Interest and similar income

 

 

 

42,196,235

 

 

 

42,600,957

Interest and similar expense

 

 

 

(17,023,815)

 

 

 

(21,022,338)

Net interest income

6

 

 

25,172,420

 

 

 

21,578,619

 

 

 

 

 

 

 

 

 

Fee and commission income

 

 

 

3,059,264

 

 

 

3,451,688

Fee and commission expense

 

 

 

(983,450)

 

 

 

(1,170,893)

Net fee and commission income

7

 

 

2,075,814

 

 

 

2,280,795

 

 

 

 

 

 

 

 

 

Dividend income

8

 

 

50,175

 

 

 

53,423

Net trading income

9

 

 

406,631

 

 

 

688,059

Profits (Losses) on financial investments

21

 

 

922,832

 

 

 

450,697

Administrative expenses

10

 

 

(5,625,883)

 

 

 

(5,048,922)

Other operating (expenses) income

11

 

 

(2,742,996)

 

 

 

(1,794,750)

Goodwill amortization

 

 

 

(27,505)

 

 

 

-

Intangible assets amortization

 

 

 

(6,911)

 

 

 

(238,715)

Impairment release (charges) for credit losses

12

 

 

(5,018,781)

 

 

 

(1,435,460)

Profits from subsidiaries acquisition

 

 

 

8,086

 

 

 

-

Bank's share in the profits of associates

 

 

 

22,426

 

 

 

1,135

Profit before income tax

 

 

 

15,236,308

 

 

 

16,534,881

 

 

 

 

 

 

 

 

 

Income tax expense

13

 

 

(5,087,418)

 

 

 

(4,639,364)

Deferred tax assets (Liabilities)

31 - 13

 

 

87,433

 

 

 

(94,522)

Net profit for the year

 

 

 

10,236,323

 

 

 

11,800,995

Minority interest

 

 

 

(1,834)

 

 

 

-

Bank shareholders

 

 

 

10,238,157

 

 

 

11,800,995

 

 

 

 

 

 

 

 

 

Earning per share

14

 

 

 

 

 

 

 

Basic

 

 

 

6.26

 

 

 

7.11

Diluted

 

 

 

6.24

 

 

 

7.09

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

 

Sherif Samy

CEO & Board member

 

Chairman

          

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated statement of other comprehensive income for the year ended December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

Dec. 31, 2020

 

 

Dec. 31, 2019

 

 

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

 

Net profit for the year

 

 

 

10,236,323

 

 

11,800,995

 

 

 

 

 

 

 

 

 

 

Other comprehensive income items that will not be reclassified to the Profit or Loss:

 

 

 

 

 

 

 

 

Change in fair value of equity instruments measured at fair value through other comprehensive income

 

 

 

(13,966)

 

 

212,967

 

 

 

 

 

 

 

 

 

 

Other comprehensive income items that is or may be reclassified to the profit or loss:

 

 

 

 

 

 

 

 

Change in fair value of debt instruments measured at fair value through other comprehensive income

 

 

 

(250,766)

 

 

5,944,586

 

Transferred from reserve on disposal of financial assets at fair value through OCI

 

 

 

(76,717)

 

 

-

 

Cumulative foreign currencies translation differences

 

 

 

(3,684)

 

 

2,501

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

 

 

 

205,182

 

 

(184,921)

 

Total other comprehensive income for the year

 

 

 

10,096,372

 

 

17,776,128

 

 

 

 

 

 

 

 

 

 

As follows:

 

 

 

 

 

 

 

 

Bank's shareholders

 

 

 

10,098,206

 

 

17,776,128

 

Minority interest

 

 

 

(1,834)

 

 

-

 

Total other comprehensive income for the year

 

 

 

10,096,372

 

 

17,776,128

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated cash flow for the year ended December 31, 2020

 

 

 

 

 

 

Notes

Dec. 31, 2020

 

Dec. 31, 2019

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

Profit before income tax from continued operations

 

15,236,308

 

16,534,881

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

 

 

Fixed assets depreciation

24

733,032

 

576,544

Impairment charge for credit losses (Loans and advances to customers and banks)

12

4,806,518

 

1,610,878

Other provisions charges

29

1,234,980

 

461,869

Impairment charge for credit losses (due from banks)

12

7,081

 

9,503

Impairment charge for credit losses (financial investments)

12

205,182

 

(184,921)

Impairment charge for other assets

23

69,217

 

(93,313)

Exchange revaluation differences for financial assets at fair value through OCI

21

249,642

 

1,593,030

Goodwill amortization

42

27,505

 

-

Intangible assets amortization

43

6,911

 

238,715

Impairment charge financial assets at fair value through OCI

21

79,126

 

-

Utilization of other provisions

29

(2,382)

 

(28,135)

Other provisions no longer used

29

(13,273)

 

(6,910)

Exchange differences of other provisions

29

(7,193)

 

(110,062)

Profits from selling property, plant and equipment

11

(1,094)

 

(1,439)

(Profits) losses from selling financial investments

21

(1,018,469)

 

(497,894)

Released (Impairment) charges of investments in associates and subsidiaries

21

16,511

 

-

Shares based payments

 

552,438

 

464,539

Bank's share in the profits of associates

 

(22,426)

 

(1,135)

Operating profits before changes in operating assets and liabilities

 

22,159,614

 

20,566,150

 

 

 

 

 

Net decrease (increase) in assets and liabilities

 

 

 

 

Due from banks

15

(10,899,927)

 

(8,870,547)

Treasury bills and other governmental notes

 

-

 

-

Financial assets at fair value through P&L

21

58,822

 

2,318,924

Derivative financial instruments

20

16,109

 

(2,910)

Loans and advances to banks and customers

18 - 19

(5,020,609)

 

(14,533,328)

Other assets

40

568,988

 

163,933

Due to banks

25

(2,993,072)

 

4,550,788

Due to customers

26

36,720,995

 

19,151,586

Income tax obligations paid

 

(3,779,782)

 

(3,625,579)

Other liabilities

28

(7,645,182)

 

1,895,241

Net cash used in (generated from) operating activities

 

29,185,956

 

21,614,258

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

Proceeds from Investments in associates.

 

750

 

-

Payment for purchases of property, plant, equipment and branches constructions

 

(1,091,829)

 

(1,303,181)

Proceeds from selling property, plant and equipment

11

1,094

 

1,439

Proceeds from redemption of financial assets at amortized cost

21

82,309,481

 

43,937,957

Payment for purchases of financial assets at amortized cost

21

(233,765)

 

(76,516,842)

Payment for purchases of financial assets at fair value through OCI

21

(112,791,966)

 

(50,954,311)

Proceeds from selling financial assets at fair value through OCI

 

54,137,187

 

54,855,966

Proceeds from investment in subsidiaries.

 

194,722

 

-

Net cash generated from (used in) investing activities

 

22,525,674

 

(29,978,972)

 

 

 

 

 

 

 

 

 

 

 

Consolidated cash flow for the year ended December 31, 2020 (Cont.)

 

 

 

 

 

 

 

Dec. 31, 2020

 

Dec. 31, 2019

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

Received (Repaid) in long term loans

27

4,474,200

 

(448,783)

Dividend paid

 

(3,370,464)

 

(2,700,544)

Capital increase

 

85,992

 

105,413

Net cash generated from (used in) financing activities

 

1,189,728

 

(3,043,914)

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalent during the year

 

52,901,358

 

(11,408,628)

Beginning balance of cash and cash equivalent

 

22,895,017

 

34,303,645

Cash and cash equivalent at the end of the year

 

75,796,375

 

22,895,017

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

Cash and balances at the central bank

15

33,768,549

 

28,273,962

Due from banks

16

87,450,490

 

28,370,183

Treasury bills and other governmental notes

17

39,497,692

 

27,634,062

Obligatory reserve balance with CBE

15

(27,744,700)

 

(22,397,310)

Due from banks with maturities more than three months

 

(16,974,367)

 

(10,593,903)

Treasury bills with maturity more than three months

 

(40,201,289)

 

(28,391,977)

Total cash and cash equivalent

 

75,796,375

 

22,895,017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated statement of changes in shareholders' equity for the year ended December 31, 2019

 

 

 

 

 

 

Dec. 31, 2019

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Minority Interest

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

Beginning balance

11,668,326

1,710,293

12,776,215

1,549,445

-

12,421

(1,860,851)

4,323

9,637,083

738,320

-

36,235,575

-

36,235,575

Capital increase

3,022,495

-

(2,917,082)

-

-

-

-

-

-

-

-

105,413

-

105,413

Transferred to reserves

-

477,736

6,615,296

-

-

1,045

-

-

(6,854,370)

(239,707)

-

-

-

-

Dividend paid

-

-

-

-

-

-

-

-

(2,700,544)

-

-

(2,700,544)

-

(2,700,544)

Net profit of the year

-

-

-

-

-

-

-

-

11,800,995

-

-

11,800,995

-

11,800,995

Reserve for transactions under common control

-

-

-

-

-

-

6,157,553

-

-

-

-

6,157,553

-

6,157,553

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

841

(841)

-

-

-

-

-

ECL for impairment of debt instruments investments

-

-

-

-

-

-

(184,921)

-

-

-

-

(184,921)

-

(184,921)

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

464,539

-

464,539

-

464,539

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

(666)

-

2,501

1,835

-

1,835

Balance at the end of the year

14,690,821

2,188,029

16,474,429

1,549,445

-

13,466

4,111,781

5,164

11,881,657

963,152

2,501

51,880,445

-

51,880,445

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated statement of changes in shareholders' equity for the year ended December 31, 2020

 

 

 

 

 

 

Dec. 31, 2020

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Minority Interest

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

Beginning balance

14,690,821

2,188,029

16,474,429

1,549,445

-

13,466

4,111,781

5,164

11,881,657

963,152

2,501

51,880,445

-

51,880,445

Capital increase

85,992

-

-

-

-

-

-

-

-

-

-

85,992

-

85,992

Transferred to reserves

-

590,106

8,291,229

-

-

1,440

-

-

(8,431,833)

(450,942)

-

-

-

-

Dividend paid

-

-

-

-

-

-

-

-

(3,370,464)

-

-

(3,370,464)

-

(3,370,464)

Minority Interest share

-

-

-

-

 

-

-

-

-

-

-

-

485,779

485,779

Net profit of the year

-

-

-

-

-

-

-

-

10,238,157

-

-

10,238,157

(1,834)

10,236,323

Transferred from reserve on disposal of financial assets at fair value through OCI

-

-

-

-

-

-

(76,717)

-

76,717

-

-

-

-

-

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

-

101,013

-

-

101,013

-

101,013

Change in retained earnings from acquisition of subsidiaries

-

-

-

-

-

-

-

-

45,727

-

-

45,727

-

45,727

Reserve for transactions under common control

-

-

-

-

8,183

-

-

-

-

-

-

8,183

-

8,183

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

-

(264,732)

-

-

-

-

(264,732)

-

(264,732)

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

1,259

(1,259)

-

-

-

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

-

205,182

-

-

-

-

205,182

-

205,182

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

552,438

-

552,438

-

552,438

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

(6,185)

(6,185)

(890)

(7,075)

Balance at the end of the year

14,776,813

2,778,135

24,765,658

1,549,445

8,183

14,906

3,975,514

6,423

10,539,715

1,064,648

(3,684)

59,475,756

483,055

59,958,811

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR EAEDFEEPFEEA
Date   Source Headline
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.